This article provides an overview of the trade challenges faced by US pharmaceutical companies in Russia. It discusses the political and regulatory barriers, intellectual property protection issues, and market access challenges that hinder their operations. The article also examines the impact of unsettled accounts on US pharma’s trade with Russia,…